Powered by our drug discovery computational platform ALEMBIC™and enabled by our proprietary chemistry engineering, Rubedo makes novel drugs designed to be selective, safe and well tolerated.
Rubedo’s lead small molecules are engineered to be selectively activated in pathological cells that drive age-related diseases.